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Abstract
Mitochondrial dysfunction and oxidative stress are the major events that lead to the formation of
mitochondrial permeability transition pore (mPTP) during glutamate-induced cytotoxicity and cell
death. Coenzyme Q10 (CoQ10) has widely been used for the treatment of mitochondrial disorders and
neurodegenerative diseases. Comparing to traditional lipid-soluble CoQ10, water soluble CoQ10
(Ubisol-Q10) has high intracellular and intra-mitochondrial distribution. The aims of the present study
are to determine the neuroprotective effects of Ubisol-Q10 on glutamate-induced cell death and to
explore its functional mechanisms. HT22 neuronal cells were exposed to glutamate. Cell viability was
measured and mitochondrial fragmentation was assessed by mitochondrial imaging. The mPTP opening
was determined by mitochondrial membrane potential and calcium retention capacity. The results
revealed that the anti-glutamate toxicity effects of Ubisol-Q10 was associated with its ability to block
mitochondrial fragmentation, to maintain calcium retention capacity and mitochondrial membrane
potential, and to prevent mPTP formation, AIF release, and DNA fragmentation. We concluded that
Ubisol-Q10 protects cells from glutamate toxicity by preserving the integrity of mitochondrial structure
and function. Therefore, adequate CoQ10 supplementation may be beneficial in preventing cerebral
stroke and other disorders that involve mitochondrial dysfunction.
Key words: Coenzyme Q10, glutamate toxicity, neuronal cell death, AIF, mitochondrial fragmentation, calcium
retention.

Introduction
Mitochondrial dysfunction due to glutamate
toxicity is one of the major events that accelerates
neuronal cell death during acute brain injury such as
ischemia/stroke, traumatic brain injury, and chronic
neurodegenerative diseases including Alzheimer
disease, Parkinson’s disease, and amyotrophic lateral
sclerosis [1]. Mitochondrial dysfunction due to
glutamate toxicity is mediated by receptor-initiated
excitotoxicity [2, 3] and non-receptor mediated

oxidative toxicity as a result of depletion of
intracellular cysteine and glutathione [4]. This leads to
excessive accumulation of reactive oxygen species,
resulting in oxidative stress [4, 5]. Emerging evidence
indicates that oxidative stress due to excessive
generation of reactive oxygen species can affects
mitochondria
adversely
[6].
Mitochondrial
dysfunction releases various factors including
cytochrome c, apoptosis-inducing factor (AIF),
http://www.ijbs.com
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Smac/Diablo (second mitochondria-derived activator
of caspase/direct IAP binding protein with low PI), or
endonuclease G which are responsible for activation
of caspase-dependent or caspase-independent
mechanisms of DNA degradation and cell death [7].
One of the major sites of reactive oxygen species
(ROS) production in the cell is the mitochondria.
Mitochondrial ROS is produced upon leakage of
electrons through complex I (NADH-ubiquinone
oxidoreductase) or III (ubiquinone-cytochrome c
oxidoreductase) of the mitochondrial respiratory
chain [8]. The products of this leakage are superoxide
anions and hydrogen peroxide. Superoxide is
converted by the antioxidant enzyme superoxide
dismutase (SOD) into hydrogen peroxide in the
mitochondria (SOD2 or MnSOD) or in the cytosol
(SOD1 or CuZnSOD). Hydrogen peroxide is further
simplified to water by glutathione peroxidase.
Oxidative stress due to depletion of antioxidant or
excessive accumulation of ROS has detrimental effect
on mitochondrial structure and function. Moreover,
oxidative stress and mitochondrial dysfunction are
the primary events in glutamate-induced toxicity [9].
Mitochondria in healthy neurons resemble long,
yet remarkably dynamic filaments undergoing cycles
of mitochondrial fission and fusion events. Fission
processes are regulated by dynamin-related protein 1
(Drp1), Mitochondrial fission 1 protein (Fis1), and
endophilin B1 (Endo B1); while fusion process is
mediated by mitofusin-1 and -2 (Mfn1, -2) and optic
atrophy 1 (OPA1) [10]. Disturbance in mitochondrial
dynamics toward continuous fission leads to
mitochondrial fragmentation, formation of mPTP, and
activation of apoptosis and neurodegeneration
[11-15]. Drp1, which induces mitochondrial fission,
has been reported to stimulate Bid-induced Bax
oligomerization and cytochrome c release by
promoting tethering and hemifusion of membranes
[16]. Bax knockdown drastically inhibited the
mitochondrial accumulation of Drp 1 and Drp1
knockdown attenuated cell apoptosis [17]. Drp1/Bax
activation promotes mitochondrial fragmentation,
reduces mitochondrial number, and activates
apoptotic cell death [18]. We have recently
demonstrated that glutamate exposure induces
mitochondrial fragmentation [5]. It is not clear
whether coenzyme Q10 (CoQ10) is capable of
preventing mitochondrial fragmentation caused by
glutamate exposure.
Ubiquinone CoQ10 (coenzyme Q10, CoQ10) is a
well-known electron transporter of the mitochondrial
respiratory chain that shuttles electrons from complex
I and II (succinate-ubiquinone oxidoreductase) to
complex III during oxidative phosphorylation and
energy production. It is normally synthesized in the
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body. However, the levels of CoQ10 decrease with
genetic mutation, cancer, ageing in human and animal
tissues. Whole body concentration of CoQ10 is also
affected by certain drugs such as statins that inhibit
the synthesis of CoQ10 in patients with a risk of
cardiovascular diseases and stroke [19-21]. Deficiency
of CoQ10 can cause varying clinical syndromes,
including encephalomyopathy, mental retardation,
recurrent myoglobinuria, isolated myopathy, etc.
[22-24]. Supplementation of CoQ10 can restore
normal mitochondrial concentration levels in aging
[25-27]. Available evidence suggests that besides the
above essential role, CoQ10 also acts as a ubiquitous
free radical scavenger and has been shown to
ameliorate cell death and protects cells under various
stress conditions including neurodegeneration
diseases [25, 28, 29]. Although, it is not clear whether
the beneficial effects of CoQ10 is only limited to its
antioxidant property, we and others have reported
that CoQ10 prevents apoptosis activated upon
mitochondrial
dysfunction
[29-35].
Similarly,
evidence of CoQ10 against glutamate-induced cell
death is lacking. Therefore, in the present study we
investigated whether CoQ10 curtails glutamate
toxicity,
prevents
cell
death,
and
offers
neuroprotective role. Further, we also explored
whether the beneficial effects of CoQ10 against
glutamate toxicity are mediated through regulating
calcium fluctuations, mPTP formation, mitochondrial
membrane potential, and mitochondrial dynamic
balance. Water-soluble CoQ10 (aka Ubisol-Q10) was
developed to overcome low bioavailability of
traditional oil-soluble CoQ10 when taken orally [36].
Because traditional oil-soluble CoQ10 has a low
bioavailability when taken orally, we decided to use
the water soluble Q10 (aka Ubisol-Q10) for the present
study. Ubisol-Q10 has better bioavailability and
increases cellular and mitochondrial uptake by 20 to
30 fold over the oil-soluble formulation. In addition, it
is able to pass through the Blood-Brain Barrier (BBB)
[37, 38]. Our data indicates that glutamate challenge
induces mitochondrial dysfunction through ROS
generation and mitochondrial membrane potential
alteration. This further activates mitochondrial fission
that results in mitochondrial fragmentation and mPTP
formation. These events lead to AIF nuclear
translocation, DNA fragmentation, and cell death.
Ubisol-Q10 pre-treatment prevents mitochondrial
dysfunction, stabilizes the mitochondrial membrane
potential, blocks mPTP formation, prevents AIF
nuclear
translocation
and
nuclear
DNA
fragmentation, and subsequent cell death. These
results clearly indicate that Ubisol-Q10 offers
neuroprotective benefits partly through preserving
mitochondrial dynamic balance and function and
http://www.ijbs.com
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preventing apoptotic cell damage.

Materials and Methods
Cell culture, experimental treatments and
viability assays
Murine hippocampal HT22 neuronal cells were
cultured in Dulbecco's Modified Eagle Medium
(DMEM, Invitrogen) supplemented with 10%
heat-inactivated fetal bovine serum (FBS), 2 mM
glutamine, and 200 mM streptomycin/penicillin
(Invitrogen) and maintained at 90%-95% relative
humidity in 5% CO2 at 37 °C. Glutamate (Sigma) and
Ubisol-Q10 (Zymes LLC) were dissolved in water.
The stock solutions were diluted with cell culture
medium for each experiment. Cells were subjected to
glutamate stress 24 h after Ubisol-Q10 treatment.
Varying concentrations (1-5 mM) of glutamate [5] and
Ubisol-Q10 (10-25 µg) were tested and evaluated for
cell viability after 24 h of treatment. Quantification of
cell viability in HT22 cells was performed in 96-well
plates
with
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. HT22 cells
were seeded at a density of 10,000 cells per well. After
24 h of treatment, cells in each well were incubated
with 10 μl MTT (5 mg/ml) at a final concentration of
500 μg/ml. After 2 h the medium was removed from
the wells and formazan formed was dissolved in
dimethyl sulfoxide (DMSO, 80 μl). The absorbance
was
read
with
a
dual-monochromator,
multi-detection microplate reader (SpectraMax M5
Molecular Device, Sunnyvale, CA) at 540 nm. Cell
viability was expressed as a percent of the control.
For drug treatment, antioxidant Trolox,
staurosporine,
hydrogen
peroxide
(H2O2),
cyclosporine, and sodium azide were used to
delineate the effects of Ubisol-Q10.

Detections of ROS levels and calcium
retention capacity
Intracellular superoxide anion production was
determined using dihydroethidium (DHE) as a
fluorescent probe. Briefly, cells (2x106/ml) were
incubated with the DHE (2.5 μM) for 30 min at 37ºC,
after which they were washed, resuspended in
phosphate buffered saline (PBS), and analyzed for
fluorescent signal intensity using Fluoromax-4
spectrofluorometer at the excitation and emission
wavelengths of 480 nm and 590 nm respectively. The
florescence was recorded and represented as relative
fluorescence intensity (RFI).
For measuring calcium retention capacity of the
mitochondria, HT22 cells (5×106) were harvested,
washed with PBS and permeabilized immediately
with digitonin (50 µg/ml) for 2 min at 25°C in a Ca2+
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free KCl medium (125 mM KCl, 2 mM K2HPO4, 1 mM
MgCl2, 20 mM HEPES, pH 7.0) [37] Measurements of
Ca2+ were performed fluorimetrically at 37°C with a
FluoroMax-4 spectrofluorometer equipped with
magnetic stirring and thermostatic controls.
Extra-mitochondrial Ca2+ was measured in the
presence of 1 µM Calcium Green-5N, 10 mM
glutamate, 0.5 mM malate or 10mM succinate with
excitation and emission wavelengths set at 506 and
530 nm respectively. The free calcium (Ca2+) uptake
and Ca2+ release of digitonin-permeabilized cells were
measured by loading cells with Ca2+ pulses at
constant time intervals.

Measurement of mitochondrial membrane
potential
Mitochondrial
membrane
potential
was
measured
using
JC-1
dye.
JC-1
exhibits
potential-dependent accumulation in mitochondria
with a fluorescence emission shift from green (~529
nm) to red (~590 nm). Briefly, HT22 cells were grown
on Lab-Tek II Chamber Slide (Thermo Scientific) and
incubated with JC-1 dye (5 µg/ml). JC-1 was excited at
488 nm and emission of JC-1 monomer (depolarized)
and J-aggregate (polarized mitochondria) forms were
captured at 525/50 and 605/75 nm, respectively, with
Nikon laser-scanning confocal microscope (Nikon
Eclipse C1). To avoid the photobleaching, laser power
was attenuated to the minimal level. Minimum three
fields per group were captured to determine the
changes in mitochondrial membrane potential.
Carbonylcyanide
p-trifluoromethoxyphenylhydrazone (FCCP 5 µM) was used as a control to dissipate
mitochondrial potential.

Subcellular fractions and Immunoblotting
Mitochondrial and cytosolic fractions were used
in the study and the fractions were isolated as
described previously [5]. Briefly, cells were washed
with PBS and resuspended in cytosolic lysis buffer
(250 mM sucrose, 70 mM KCl, 137 mM NaCl, 4.3 mM
Na2HPO4, 1.4 mM KH2PO4 pH 7.2, 200 μg/ml
digitonin, 100 mM PMSF, protease inhibitor cocktail
(Halt, Thermo Scientific) for 5 min on ice. These cells
were centrifuged at 1,000 × g for 5 min to separate the
supernatant as a cytosolic fraction and the pellet was
resuspended in two volumes of mitochondrial lysis
buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2 mM
EDTA, 2 mM EGTA, 0.2% (v/v) Triton X-100, 0.3%
NP-40, PMSF, protease inhibitor cocktail) for 5 min on
ice. The resulting suspension was centrifuged at
10,000 × g for 10 min and the supernatant was
collected as the mitochondrial fraction. The purity of
the fractions has been previously verified [39]. Protein
concentration was determined using the Bradford
http://www.ijbs.com
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assay and same amount of protein (20 µg) was loaded
into each lane of a 4-12% NuPAGE gel (Invitrogen).
Following electrophoresis, proteins were transferred
to a nitrocellulose membrane (Invitrogen) and
blocked for nonspecific binding with 5% skim milk.
The membrane was incubated for target proteins
using primary antibodies specific for Drp1 (1:1000,
8570, Cell Signaling USA), phospho-Drp1 (Ser616
1:800, 3455, Cell Signaling USA), Fis1 (1:500, sc-98900,
MBL,MA USA), AIF (1:500, sc-9416, Santa Cruz
Biotechnology, CA, USA), cytochrome C (1:500,
sc-13560, Santa Cruz Biotechnology, CA, USA),
VDAC (1 µg/ml ab14744, Abcam Inc, MA, USA) or
Actin (1:1000,sc-1616, Santa Cruz Biotechnology, CA,
USA) overnight at 4°C. The membranes were
incubated with horseradish peroxidase-conjugated
secondary antibodies for 1 h at room temperature. The
blots were then developed using the Pierce ECL
Western Blotting Substrate (Thermo Scientific). The
β-actin or VDAC bands were used as internal loading
controls and the ratios of the targeted proteins and
loading control were calculated and presented as final
results.

Mitochondrial morphometrics
HT22 cells were grown on Lab-Tek II Chamber
Slide (Thermoscientific). Mitochondrial staining was
carried out with MitoTracker®Red CM-XRos
(Invitrogen) as described previously [5]. DAPI was
used to label nuclei. Minimum 3 images were
captured in each well for analyses using the Nikon
laser-scanning
confocal
microscope
at
the
magnification of 63X. An image process program was
designed to identify and quantify mitochondria
structures from the RGB images according to the
published method [40, 41]. In brief, we first created a
mask to filter out the nucleus regions that are mostly
blue. Next, we extracted only the red channel and
converted it to a gray-scale image. The resulting
image was adjusted to increase contrast. A "top-hat"
spatial filter was applied in order to isolate bright
features from a dark background using a flat,
disk-shaped structuring element with a radius of 2
pixels. In order to reduce noise while preserving
edges, a 2-D median filtering with a dimension of 3 x 3
pixels was applied twice. An additional threshold was
applied to remove darker pixels.
For morphological analysis, three parameters
were calculated for each mitochondrial object: the
form factor F (perimeters2/(4π• area)), mitochondrial
perimeter and mitochondrial area. We also computed
the total number of mitochondria per cell. Form factor
is independent of image magnification and has a
minimum value of 1 (corresponding to a perfect
circle). For statistical analysis, we calculated the
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average values of F for each image.

AIF immunostaining
HT22 cells were grown on Lab-Tek II Chamber
Slides (Thermo Scientific). Cells were fixed 18 h after
glutamate exposure with 4% paraformaldehyde for
20 min, washed with PBS, and permeabilized in
Triton X-100 (0.3%) for 5 min. The cells were blocked
with 10% donkey serum for 1 h at room temperature.
After blocking, cells were incubated overnight at 4°C
with primary antibodies against AIF (1:200, Santa
Cruz Biotechnology CA). Cells were washed and
incubated for 2 h at room temperature with secondary
antibodies conjugated with Alexa Fluor 488 (1:500
dilution; Invitrogen). Finally, slides were mounted
with Vectashield mounting medium containing DAPI
(Vector Laboratories). Slides were scanned with a
Nikon laser-scanning confocal microscope. The
experiment was repeated thrice and, at minimum,
three fields per group were captured and processed
for analysis.

DNA fragmentation assay
DNA fragmentation due to apoptosis was
assessed by terminal deoxynucleotidyl transferasemediated dUTP nick-end-labeling (TUNEL) assay
using a DeadEnd Fluorometric TUNEL system kit
(Promega, USA) per the kit instructions. A minimum
of three random fields per group were captured.
TUNEL positive cells were counted and presented as
percent of total cells.

Statistical analysis
Data are presented as mean±SD and analyzed
with GraphPad Prism 5 software. One-way ANOVA
followed by Tukey’s multiple comparison test and
two-way ANOVA followed by Bonferoni test were
used when appropriate. A p<0.05 is considered
statistically significant.

Results
Pretreatment of HT22 cells with Ubisol-Q10
blocked glutamate-induced cell death
To determine the neuroprotective role of Q10,
we exposed Ubisol-Q10 pretreated and untreated
HT22 neuronal cells to glutamate and cell survival
was determined by MTT assay and cellular
morphology (Fig. 1). Glutamate induced cell death in
HT22 cells in a dose (data not shown) and time
dependent manner [5]. Therefore, the cell survival
was limited to around 20 % of control (Fig. 1A and B)
with 4 mM of glutamate after 24 h of exposure [5]. In
contrast, Ubisol-Q10 alone up to the 25 µg/ml range
was well tolerated by HT22 neurons without any
influence on cell viability (Fig. 1A). Interestingly,
http://www.ijbs.com
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Ubisol-Q10 (10-25 µg/ml) blocked glutamate-induced
death in HT22 cells; thereby significantly (p<0.001)
improved the cell survival (from 21 to 87 %) of control
HT22 cells (Fig. 1A and B). The Ubisol-Q10-induced
protection was not transiently limited to 24 h as the
rescue effects were also noticed up to 48 h of
glutamate exposure (data not shown), suggesting the
long-term protective effect of Ubisol-Q10.

Ubisol-Q10 decreased ROS levels and
stabilized mitochondrial membrane potential
We have previously shown that glutamate
exposure alters ROS levels and mitochondrial
membrane potential [5]. In the present study, we set
the baseline level of ROS production in control cells as
100%. Exposure of HT22 neurons to glutamate
resulted in enhanced ROS formation when measured
after 18 h (p<0.05). Presently, we determined whether
Ubisol-Q10 treatment could prevent the increase in
ROS production and whether this effect is associated
with stabilizing mitochondrial potential (Fig. 2).
Results revealed that glutamate induced the
generation of ROS whereas Ubisol-Q10 treatment
curtailed it (Fig. 2A).
Likewise, glutamate also affected mitochondrial
membrane potential. Glutamate exposure resulted in
membrane depolarization as reflected by the increase
in green fluorescence of JC-1 monomer. Pretreatment
with Ubisol-Q10 prevented glutamate-induced
mitochondrial membrane depolarization as reflected
by the predominant red fluorescence of JC-1
aggregates that were taken by normal polarized
mitochondria. Non-treated control cells and cells
treated with Ubisol-Q10 alone maintained normal
mitochondrial potential (Fig. 2B).
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To determine whether glutamate-induced cell
death is mediated by increased free ROS production
and loss of mitochondrial potential through formation
of mPTP, we used free radical scavenger Trolox and
Cyp-D /ANT channel inhibitor cyclosporine. Cell
viability study results revealed that Trolox
significantly ameliorated glutamate toxicity (Fig. 2C),
while cyclosporine A failed to prevent glutamate
induced cell death in HT22 cells (Data not shown).
These results suggest that glutamate-induced cell
death is mediated through formation of ROS and
mPTP independent of Cyp-D /ANT.

Ubisol-Q10 prevented glutamate-reduced
calcium retention capacity
Mitochondria have been shown to transiently
store calcium and thereby regulating cellular
Ca2+ homeostasis. Reduction or loss of calcium
retention capacity of the mitochondria leads to
formation of mPTP and opening of mPTP has been
shown to be a primary mediator of cell death. We
investigated whether glutamate lowers calcium
retention capacity and whether Ubisol-Q10 could
improve it. Mitochondrial calcium uptake capacity
was detected using Calcium Green-5N. Addition of
calcium causes increase in extra-mitochondrial
calcium and then the concentration decreased as the
calcium is taken up by the mitochondria. Under
normal condition, cells with Ubisol-Q10 addition did
not differ in mitochondrial calcium uptake capacity as
compared to control cells. After glutamate exposure,
calcium retention capacity was decreased compared
to control cells. Ubisol-Q10 pretreatment in
glutamate-exposed cells restored the calcium
retention capacity to control level (Fig. 3).

Figure 1: Ubisol-Q10 blocks glutamate toxicity-induced cell death. (A) Concentration-dependent effect of water soluble Ubisol-Q10 on HT22 cell viability alone and
with 4 mM glutamate. Ubisol-Q10 was added to the cell media prior to the glutamate exposure and cell viability was estimated 24 h after addition. Ubisol-Q10 alone upto 25 µg
had no effect on cell viability whereas glutamate exposure significantly reduced the survival of cells to nearly 20 % of control. Pretreatment of cells with Ubisol-Q10 resisted the
effect of glutamate toxicity thereby showed significant reduction in cell mortality. Ubisol-Q10 concentration of 15 μg showed maximum protection to glutamate induced cell
death in HT222 cells. (B) Representative photomicrograph of HT22 cells treated with Ubisol-Q10, glutamate and both. Data are the representation of 3 or more independent
experiments conducted in triplicate. Values are means±SD and analyzed by one-way ANOVA followed by Tukey's multiple comparison test. Significant levels is shown by
***=p<0.001 vs. respective group. Glu=glutamate, Q10=Ubisol-Q10, Glu+Q10=glutamate +Ubisol-Q10 and Glu+Q10-15 to 25 = glutamate (4 mM) +Ubisol-Q10 (15-25 µg).

http://www.ijbs.com
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Figure 2: Ubisol-Q10 prevents glutamate induced ROS production and mitochondrial potential loss. (A) ROS production were measured using DHE in
Ubisol-Q10 pretreated HT22 cells exposed to glutamate. Ubisol-Q10 normalized the glutamate exposure increased levels of ROS. (B) Micrograph of HT22 cells shows potential
loss after glutamate exposure (arrow). Ubisol-Q10 pretreatment prevented glutamate induced depolarization of mitochondrial membrane potential. Mitochondrial potential
measured with JC-1, shows red staining as normal potential whereas green staining represents depolarization and potential loss. (C) Summarized graph shows the effect of
Antioxidant Trolox and Ubisol-Q10 on glutamate-induced cell death. Data are the representation of 3 or more independent experiments conducted in triplicate. Values are
means±SD and analyzed by one-way ANOVA followed by Tukey's multiple comparison test. Significant levels is shown by *=p<0.05 and ***=p<0.001 vs. respective group.
Glu=glutamate, Q10=Ubisol-Q10 and Glu+Q10 = glutamate+Ubisol-Q10.

Figure 3: Ubisol-Q10 restores glutamate
reduced mitochondrial calcium retention
capacity. Figures show cytosolic calcium uptake by
mitochondrial in permeabilized HT22 cells. The
addition of calcium (cytosolic) indicated by an arrow
(25 µM of calcium pulse each) results in a rapid
increase in signal that subsequently decline due to
calcium uptake by mitochondria. Result shows that
glutamate exposure reduced the capacity of
mitochondrial to uptake cytosolic excessive calcium.
Ubisol-Q10 pretreatment in contrast improved the
mitochondrial calcium uptake to normal levels,
thereby maintained the mitochondrial calcium
uptake capacity. Cont=Control,

http://www.ijbs.com
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Ubisol-Q10 inhibits glutamate-induced
mitochondrial fragmentation
Previously, we have shown that glutamate
affects mitochondrial morphology in HT22 cell by
increasing mitochondrial fission, which may leads to
increased ROS formation, loss of mitochondrial
potential and calcium retention capacity, and
adversely affects mitochondrial function [5]. We
investigated whether the protective effects of
Ubisol-Q10 is mediated through preventing
mitochondrial fragmentation. Mitochondria are
organized as a tubular network under normal control
conditions. Under stress conditions, mitochondrial
fission occurs and the reticular mitochondria break
into short, round pieces, a process defined as
mitochondrial fragmentation. Mitochondrial fission
markers Drp1 and Fis1 were measured using
immunoblotting. Drp1 is normally present in the
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cytosol of the cell, but when phosphorylated at
Ser616, Drp1 translocates to the mitochondria and
stimulates mitochondrial fission. The results showed
that phospho-Drp1 and Fis1 were significantly
increased in the mitochondrial fraction, but not in the
cytosolic fraction, after 18 h of glutamate exposure.
Treatment with Ubisol-Q10 completely blocked the
phosphorylation of Drp1 and the increase in Fis1
(Fig. 4).
Consistent with the protein levels of Drp1 and
Fis1, mitochondrial imaging study using MitoTracker
Red revealed that the glutamate caused marked
mitochondrial morphologic alteration. As seen in
Figure 5, the reticularity of the mitochondrial network
was broken into small round shaped mitochondrial
pieces after 18 h of glutamate exposure. Pretreatment
with Ubisol-Q10 restored the mitochondrial tubular
network in glutamate-exposed cells (Fig. 5A).

Figure 4. Ubisol-Q10 inhibits glutamate-induced change mitochondrial fragmentation markers. Representative Western blots and quantitative analysis of the
protein band of mitochondrial fission protein Drp1, pDrp1 and Fis1. Glutamate exposure significantly increased the levels of mitochondrial fragmentation markers Drp1, pDrp1
and Fis1 without affecting the levels of VDAC and cytochrome c release after 18 h. Ubisol-Q10, in contrast blunted the corresponding elevation of Drp1, pDrp1 and Fis1 in these
cells, thereby Ubisol-Q10 significantly prevented the glutamate-induced increase in these markers. Data are the representation of 3 or more independent experiments conducted
in triplicate. Values are means±SD and analyzed by one-way ANOVA followed by Tukey's multiple comparison test. Significant levels is shown by *=p<0.05, **=p<0.01 and
***=p<0.001 vs. respective group. Glu=glutamate and Q10=Ubisol-Q10.
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Figure 5. Ubisol-Q10 preserved mitochondrial morphology. (A) Photomicrograph shows mitochondrial morphology in HT22 cells treated with glutamate and
Ubisol-Q10. Mitochondrial morphology was studied using MitoTracker Red with confocal microscopy. Images were processed and analyzed for structural alterations. Glutamate
exposure (18 h) decreased the mitochondrial reticular network resulting into small round shaped broken mitochondria. Ubisol-Q10 pretreatment restored the mitochondrial
tubular network in glutamate-exposed cells. (B) Figure shows mitochondrial perimeter and form factor (branching) analyzed from the mitochondrial micrograph. Glutamate
exposure not only lowered the mitochondrial perimeter but also reduced the mitochondrial branching. Ubisol-Q10 pretreatment blocked these effects of glutamate and thereby
restored normal mitochondrial morphology. Data are the representation of 3 or more independent experiments conducted in triplicate. Values are means±SD and analyzed by
one-way ANOVA followed by Tukey's multiple comparison test. Significant levels is shown by *=p<0.05 and **=p<0.01 vs. respective group. Glu=glutamate and
Q10=Ubisol-Q10.

To determine the effects of glutamate exposure
on mitochondrial morphology and the degree of
mitochondrial network branching in cells treated
with/without Ubisol-Q10, we determined the
mitochondrial perimeter and form factor (branching).
The result revealed that glutamate significantly
(p<0.05) lowered the mitochondrial perimeter in
HT22 cells (Fig. 5B). Pretreatment with Ubisol-Q10
restored
the
mitochondrial
perimeter
in
glutamate-exposed
cells.
Similarly, glutamate
exposure markedly affected the network of
mitochondria. Mitochondrial was significantly
(p<0.05) less branched in cells exposed to glutamate.
When pretreated with Ubisol-Q10, cells recovered
from glutamate toxicity and restored the form factor,
which clearly suggests that Ubisol-Q10 improve
cellular mitochondrial function by protecting
mitochondrial morphology (Fig. 5B).

Ubisol-Q10 blocks mitochondrial
dysfunction-induced release of AIF
Glutamate-induced cell death in HT22 cells have
been shown to be mediated by AIF dependent
apoptosis [42, 43]. Formation of mPTP may lead to
release of mitochondrial proapoptotic proteins such
as AIF and others. To examine whether
glutamate-induced mitochondrial fragmentation
caused release of proapoptotic proteins and whether

restoration of mitochondrial structure by Ubisol-Q10
could block the release of mitochondrial proteins, we
measured the levels of cytochrome c protein levels in
mitochondrial and cytosolic fractions, AIF protein in
mitochondrial and nuclear fractions and AIF
immunoreactivity (Fig 6). The results demonstrated
that cytochrome c was not released from the
mitochondria into the cytosol (Fig 4). However, AIF
immunocytochemistry showed nuclear localization of
AIF after glutamate treatment in HT22 cells and
treatment with Ubisol-Q10 significantly blocked the
AIF presence in the nuclei (Fig 6B). These results were
further confirmed by immunoblotting that showed a
significant increase of AIF protein in the nuclear
fraction after glutamate exposure and the AIF level
was markedly reduced by Ubisol-Q10 (Fig 6A).

Ubisol-Q10 reduces glutamate-induced
apoptotic injury
Detection of apoptotic cell death by TUNEL
staining revealed that incubation of cells with 4 µM
glutamate for 18 h significantly increased the number
of TUNEL-positive stained cells (Fig. 7). The average
percent of TUNEL positive cells reach to 38.7±17.9%.
In contrast, the number of TUNEL positive cell in
glutamate-exposed cells was significantly (p<0.05)
reduced by Ubisol-Q10 treatment. As a result, the
number of TUNEL positive cells reduced to
http://www.ijbs.com
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non-glutamate control level. Few TUNEL positive
cells were observed in non-treated control cells and
with Q10-treatment alone. A panel of TUNEL-stained
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images is shown in Figure 7B and percent of TUNEL
positive cells in each group is given in Figure 7B.

Figure 6: Ubisol-Q10 prevented glutamate-induced AIF release. (A) Representative Western blots and quantitative analysis of the protein bands of AIF in
mitochondrial and nuclear fractions. AIF levels were relatively similar in HT22 cells treated with glutamate and Ubisol-Q10 in mitochondrial fraction. In contrast, glutamate
exposure significantly increased AIF nuclear translocation. Ubisol-Q10 pretreatment blocked the AIF nuclear translocation in cell exposed to glutamate. (B) Photomicrograph
and quantitation of AIF positive cells. Cells shows peripheral punctuated staining in control untreated and Ubisol-Q10 only treated cells. AIF translocates to the nucleus following
glutamate exposure as shown by diffused staining. Ubisol-Q10 blocked AIF nuclear translocation. Data are the representation of 3 or more independent experiments conducted
in triplicate. Values are means±SD and analyzed by one-way ANOVA followed by Tukey's multiple comparison test. Significant levels is shown by **=p<0.01 and ***=p<0.001 vs.
respective group. Cont=Control, Glu=glutamate and Q10=Ubisol-Q10.

http://www.ijbs.com

Int. J. Biol. Sci. 2016, Vol. 12

697

Figure 7: Ubisol-Q10 prevented DNA damage in cells treated with glutamate. Photomicrograph and quantitation of cells with DNA fragmentation determined with
TUNEL staining. Glutamate increased the number of cells positive for TUNEL measure after 18 h of exposure. Ubisol-Q10 in contrast prevented the DNA fragmentation in cells
exposed to glutamate. Data are the representation of 3 or more independent experiments conducted in triplicate. Values are means±SD and analyzed by one-way ANOVA
followed by Tukey's multiple comparison test. Significance is shown by *=p<0.05 vs. respective group. Cont=Control, Glu=glutamate and Q10=Ubisol-Q10.

Discussion
Mitochondrial dysfunction due to various
reasons including oxidative stress plays a crucial role
in activation of cell death pathways. Recently, we
have shown that mitochondrial dysfunction could be
the result of mitochondrial fragmentation induced by
glutamate toxicity [5] and glutamate toxicity is a key
step in the progression of neuronal loss in acute and
chronic neurodegenerative diseases. CoQ10, in
addition to carrying electrons during oxidative
phosphorylation, positively influence many cellular
functions presumably due to its antioxidant property

[29, 32, 33, 44]. Although, it is not clear whether the
beneficial effects of CoQ10 is only limited to its
antioxidant property, we and others have reported
that
CoQ10
also
prevent
mitochondrial
dysfunction-induced activation of apoptosis [29-32,
34, 35]. Presently we demonstrate that glutamate
causes
mitochondrial
fragmentation,
mPTP
formation, calcium deregulation and mitochondrial
potential loss. These events lead to AIF nuclear
translocation, DNA fragmentation, and cell death.
Ubisol-Q10
pretreatment
prevented
glutamate-induced
cell
death
by
blocking
mitochondrial
fragmentation,
ameliorating
http://www.ijbs.com
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mitochondrial
dysfunction,
stabilizing
the
mitochondrial membrane potential, blocking the
mPTP formation, and preventing the AIF nuclear
translocation and DNA fragmentation. These results
clearly
indicate
that
Ubisol-Q10
offers
neuroprotective benefits partly through preserving
mitochondrial structure and function, which thereby
prevents cell damage.
In the present study, we have shown that
glutamate induces cell death in HT22 cells through
oxidative stress, mitochondrial dysfunction and AIF
release [5, 9, 42, 43, 45, 46]. Glutamate-induced
mitochondrial dysfunction could be the result of
mitochondrial fragmentation due to activation of
Drp1 as reported previously [5]. The fragmented
mitochondria are sensitized to Bax/Bid-dependent
pore formation and activation of apoptosis [16, 47, 48].
Drp1 is normally present in the cytosol, but once
phosphorylated at Ser616, it translocates to the
mitochondria where it localizes to potential division
sites on mitochondrial outer membrane with the help
of Fis1. In the present study, we show that glutamate
exposure not only increased the levels of Fis1 but also
increased the phosphorylation and mitochondrial
translocation of Drp1 (Fig. 4), which is consistent with
our previous finding [5]. Increased mitochondrial
Drp1 levels were well correlated with the
mitochondrial morphology (Fig. 4 and 5), suggesting
that Drp1 induces mitochondrial fragmentation in
cells exposed to glutamate. Likewise, mitochondrial
fragmentation has been shown to be associated with
increased oxidative stress and mitochondrial
depolarization, whereas inhibiting Drp1 offers
neuroprotection [43, 47].
Glutamate toxicity can also trigger calcium
influx that leads to mitochondrial calcium overload
[12] whereas, once fragmented, mitochondria reduce
their calcium buffering capacity [49]. Our study
showed that glutamate-exposed cells exhibited
impaired mitochondrial calcium loading capacity, AIF
nuclear translocation, DNA fragmentation, and cell
death (Fig. 3, Fig. 6 Fig. 7 and Fig. 1). It is likely that
mitochondrial calcium overload alone or in
combination with increased ROS production, triggers
the formation of mPTP that results in the activation of
cell death pathway. Additionally, it is believed that
glutamate-mediated oxidative stress due to increased
ROS production has been shown to be a biphasic
event in a way that glutamate induces a primary
surge in ROS production after 6-8 h and followed by a
secondary boost after 18 h [43]. The primary ROS
could be ascribed to glutamate induced glutathione
depletion as proposed previously [50], whereas the
secondary boost in ROS production could be the
result of mitochondrial fragmentation due to the
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activation of Drp1.
Furthermore, presently we showed that
glutamate-induced cell death could be prevented with
the supplementation of Ubisol-Q10 (Fig. 1). CoQ10,
which is an endogenous electron carrier in the inner
mitochondrial membrane, has been widely studied
for its antioxidative properties [29, 44]. Moreover,
Papucci et al. have reported that CoQ10 could also
prevent apoptosis in response to apoptotic stimuli
that do not generate free radicals [35]. We and others
have previously shown that cells death mechanism in
HT22 cells are activated due to mitochondrial
dysfunction [5, 9, 42, 43] and mitochondrial
dysfunction could be the result of mitochondrial
fragmentation caused by Drp1. Inhibiting Drp1
improves the survival of cells in vitro and in vivo
conditions of glutamate toxicity [45]. We presently
reported that Ubisol-Q10 blocked Drp1 mitochondrial
translocation and thereby reduced mitochondrial
fragmentation
upon
glutamate
exposure.
Mitochondria appeared tubular and branched in cells
treated with Ubisol-Q10 and Ubisol-Q10+glutmate.
Whereas, mitochondria appeared small and rounded
in glutamate only treated cells. Fragmented
mitochondria are not only prone to increased
oxidative stress and depolarization [51] but also are
sensitized to proapoptotic Bcl-2 family protein
mediated pore formation [16, 47, 48]. We found that
Ubisol-Q10 supplementation not only blocked
increase in ROS production but also prevented
mitochondrial potential loss upon glutamate exposure
(Fig 2, Fig. 4 and Fig. 5). Therefore, cells treated with
Ubisol-Q10 resisted glutamate-induced decreases of
mitochondrial
perimeter
and
mitochondrial
branching, and maintained normal mitochondrial
morphology (Fig. 4 and 5). Although, it is not clear
from the present study whether Ubisol-Q10 directly
blocks mitochondrial fragmentation by inhibiting
Drp1 or whether Ubisol-Q10 prevents the primary
surge in ROS production which is responsible for
Drp1 activation and mitochondrial fragmentation,
CoQ10 has been suggested to prevent mitochondrial
depolarization independent to its antioxidant
property [35]. In the present study, we also showed
that Ubisol-Q10 has a slightly better effect on cell
survival than antioxidant Trolox (Fig. 2C). Moreover,
evidence indicates that ROS production could be
increased following mitochondrial fragmentation [52].
By blocking mitochondrial fragmentation, Ubisol-Q10
treatment may lower ROS production and prevent the
mitochondrial
depolarization.
Mitochondrial
depolarization is an indicator of mPTP formation
during various stresses that reduce mitochondrial
calcium retention capacity [50]. Glutamate exposure
in the present study decreased mitochondrial calcium
http://www.ijbs.com
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capacity, whereas Ubisol-Q10 pretreatment restored
capacity and ultimately improved cell survival in cells
exposed to glutamate (Fig. 3, Fig. 6 and Fig. 1).
Likewise, mitochondrial fragmentation reduces the
mitochondrial calcium retention capacity and aids in
formation of mPTP though which proapoptotic
protein are released. Therefore, the present study
reveals that Ubisol-Q10 directly or indirectly blocks
Drp1 dependent mitochondrial fragmentation,
prevents mitochondrial potential loss and mPTP
formation, restores mitochondrial calcium capacity,
and inhibits AIF release and apoptotic DNA
fragmentation, and thereby improves survival in cells
exposed to glutamate. All the evidence supports that
Ubisol-Q10 offers beneficial effects by preserving
mitochondrial structure and function.

Conclusion
Glutamate causes cell death by inducing
mitochondrial fragmentation and dysfunction,
formation of mPTP, and nuclear translocation of AIF.
Ubisol-Q10 prevents glutamate-induced cell death by
blocking mitochondrial fragmentation, preserving
mitochondrial calcium retention capacity and
membrane potential, preventing mPTP formation,
AIF release, and DNA fragmentation. Ubisol-Q10
supplementation may be beneficial in ameliorating
stroke, brain and spinal traumatic injuries,
mitochondria-associated neurodegenerative and
metabolic disorders.
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